C5a modulation of interleukin-1β-induced interleukin-6 production by human osteoblast-like cells

John M. Pobanz, Richard A Reinhardt, Sreenivas Koka, Sam D. Sanderson

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Periodontal bone resorption is controlled by osteoblast products, including interleukin (IL)-6, which are stimulated by other cytokines and complement components in the pro-inflammatory milieu. This study demonstrated that human osteoblast-like osteosarcoma cells (MG-63) responded to human recombinant (hr) C5a by releasing significant amounts of the bone-resorbing cytokine IL-6. C5a-induced release of IL-6 was enhanced 330% when cells were exposed to IL-1β prior to C5a challenge at optimal concentrations (1.0 μg/ml C5a, 0.1 ng/ml IL-1β). Cells simultaneously challenged with these concentrations of C5a and IL-1β produced a 700% increase in IL-6 release relative to cells challenged with IL-1β alone. Incubation of IL-1/β-treated cells with anti-human C5a receptor (C5aR) Ab resulted in a 78% suppression of the C5a-induced release of IL-6, but C5aR neutralization did not affect C5a/IL-1β co-stimulation of IL-6. In addition, neither IL-1β nor C5a significantly altered the other's cell-surface receptor relative to binding affinity or density. These results indicate that while MG-63 cells express functional C5aRs, the synergistic effect of C5a and IL-1β on osteoblast IL-6 production is probably controlled by post-receptor signaling events. C5a agonists and antagonist used to alter critical C5a concentrations may present a new point of therapeutic intervention for the treatment of inflammatory bone resorption such as is found in periodontitis.

Original languageEnglish (US)
Pages (from-to)137-145
Number of pages9
JournalJournal of Periodontal Research
Volume35
Issue number3
DOIs
StatePublished - Jun 2000

Fingerprint

Osteoblasts
Interleukin-1
Interleukin-6
Bone Resorption
Anaphylatoxin C5a Receptor
Cytokines
Alveolar Bone Loss
Interleukin-6 Receptors
Periodontitis
Cell Surface Receptors
Osteosarcoma
Bone and Bones

Keywords

  • Cell surface molecules
  • Complement
  • Cytokines
  • Osteoblasts

ASJC Scopus subject areas

  • Periodontics

Cite this

C5a modulation of interleukin-1β-induced interleukin-6 production by human osteoblast-like cells. / Pobanz, John M.; Reinhardt, Richard A; Koka, Sreenivas; Sanderson, Sam D.

In: Journal of Periodontal Research, Vol. 35, No. 3, 06.2000, p. 137-145.

Research output: Contribution to journalArticle

@article{10a73fb09f1347ada54faa60b8460b04,
title = "C5a modulation of interleukin-1β-induced interleukin-6 production by human osteoblast-like cells",
abstract = "Periodontal bone resorption is controlled by osteoblast products, including interleukin (IL)-6, which are stimulated by other cytokines and complement components in the pro-inflammatory milieu. This study demonstrated that human osteoblast-like osteosarcoma cells (MG-63) responded to human recombinant (hr) C5a by releasing significant amounts of the bone-resorbing cytokine IL-6. C5a-induced release of IL-6 was enhanced 330{\%} when cells were exposed to IL-1β prior to C5a challenge at optimal concentrations (1.0 μg/ml C5a, 0.1 ng/ml IL-1β). Cells simultaneously challenged with these concentrations of C5a and IL-1β produced a 700{\%} increase in IL-6 release relative to cells challenged with IL-1β alone. Incubation of IL-1/β-treated cells with anti-human C5a receptor (C5aR) Ab resulted in a 78{\%} suppression of the C5a-induced release of IL-6, but C5aR neutralization did not affect C5a/IL-1β co-stimulation of IL-6. In addition, neither IL-1β nor C5a significantly altered the other's cell-surface receptor relative to binding affinity or density. These results indicate that while MG-63 cells express functional C5aRs, the synergistic effect of C5a and IL-1β on osteoblast IL-6 production is probably controlled by post-receptor signaling events. C5a agonists and antagonist used to alter critical C5a concentrations may present a new point of therapeutic intervention for the treatment of inflammatory bone resorption such as is found in periodontitis.",
keywords = "Cell surface molecules, Complement, Cytokines, Osteoblasts",
author = "Pobanz, {John M.} and Reinhardt, {Richard A} and Sreenivas Koka and Sanderson, {Sam D.}",
year = "2000",
month = "6",
doi = "10.1034/j.1600-0765.2000.035003137.x",
language = "English (US)",
volume = "35",
pages = "137--145",
journal = "Journal of Periodontal Research",
issn = "0022-3484",
publisher = "Blackwell Munksgaard",
number = "3",

}

TY - JOUR

T1 - C5a modulation of interleukin-1β-induced interleukin-6 production by human osteoblast-like cells

AU - Pobanz, John M.

AU - Reinhardt, Richard A

AU - Koka, Sreenivas

AU - Sanderson, Sam D.

PY - 2000/6

Y1 - 2000/6

N2 - Periodontal bone resorption is controlled by osteoblast products, including interleukin (IL)-6, which are stimulated by other cytokines and complement components in the pro-inflammatory milieu. This study demonstrated that human osteoblast-like osteosarcoma cells (MG-63) responded to human recombinant (hr) C5a by releasing significant amounts of the bone-resorbing cytokine IL-6. C5a-induced release of IL-6 was enhanced 330% when cells were exposed to IL-1β prior to C5a challenge at optimal concentrations (1.0 μg/ml C5a, 0.1 ng/ml IL-1β). Cells simultaneously challenged with these concentrations of C5a and IL-1β produced a 700% increase in IL-6 release relative to cells challenged with IL-1β alone. Incubation of IL-1/β-treated cells with anti-human C5a receptor (C5aR) Ab resulted in a 78% suppression of the C5a-induced release of IL-6, but C5aR neutralization did not affect C5a/IL-1β co-stimulation of IL-6. In addition, neither IL-1β nor C5a significantly altered the other's cell-surface receptor relative to binding affinity or density. These results indicate that while MG-63 cells express functional C5aRs, the synergistic effect of C5a and IL-1β on osteoblast IL-6 production is probably controlled by post-receptor signaling events. C5a agonists and antagonist used to alter critical C5a concentrations may present a new point of therapeutic intervention for the treatment of inflammatory bone resorption such as is found in periodontitis.

AB - Periodontal bone resorption is controlled by osteoblast products, including interleukin (IL)-6, which are stimulated by other cytokines and complement components in the pro-inflammatory milieu. This study demonstrated that human osteoblast-like osteosarcoma cells (MG-63) responded to human recombinant (hr) C5a by releasing significant amounts of the bone-resorbing cytokine IL-6. C5a-induced release of IL-6 was enhanced 330% when cells were exposed to IL-1β prior to C5a challenge at optimal concentrations (1.0 μg/ml C5a, 0.1 ng/ml IL-1β). Cells simultaneously challenged with these concentrations of C5a and IL-1β produced a 700% increase in IL-6 release relative to cells challenged with IL-1β alone. Incubation of IL-1/β-treated cells with anti-human C5a receptor (C5aR) Ab resulted in a 78% suppression of the C5a-induced release of IL-6, but C5aR neutralization did not affect C5a/IL-1β co-stimulation of IL-6. In addition, neither IL-1β nor C5a significantly altered the other's cell-surface receptor relative to binding affinity or density. These results indicate that while MG-63 cells express functional C5aRs, the synergistic effect of C5a and IL-1β on osteoblast IL-6 production is probably controlled by post-receptor signaling events. C5a agonists and antagonist used to alter critical C5a concentrations may present a new point of therapeutic intervention for the treatment of inflammatory bone resorption such as is found in periodontitis.

KW - Cell surface molecules

KW - Complement

KW - Cytokines

KW - Osteoblasts

UR - http://www.scopus.com/inward/record.url?scp=0034202557&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034202557&partnerID=8YFLogxK

U2 - 10.1034/j.1600-0765.2000.035003137.x

DO - 10.1034/j.1600-0765.2000.035003137.x

M3 - Article

C2 - 10929868

AN - SCOPUS:0034202557

VL - 35

SP - 137

EP - 145

JO - Journal of Periodontal Research

JF - Journal of Periodontal Research

SN - 0022-3484

IS - 3

ER -